Ten Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2018

In this online program faculty discuss how to leverage 10 of the emerging and most clinically important biomarkers to optimize patient care across multiple tumor types from solid tumors to hematologic malignancies.

Learn about biomarkers agnostic to tumor type as well as an in-depth look at case studies in non-small-cell lung cancer acute myeloid leukemia and chronic lymphocytic leukemia for examples of personalized medicine in 2018.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Supporters

This activity is supported by educational grants from

AbbVie

Agios Pharmaceuticals

Bayer Healthcare Pharma

Celgene TEXT Only

Foundation Medicine

Loxo Oncology

Merck Oncology